Publications in Vascular liver diseases in June-July 2018

[Akash Shukla]

Here we are again. A quick look at some of the articles in vascular liver diseases published in the months of June and July 2018. Enjoy reading friends !!!

1. Ultrasonography in Liver Vascular Disease.
De Gottardi A, Berzigotti A, Buscarini E, García Criado A.
Ultraschall Med. 2018 Aug;39(4):382-405. doi: 10.1055/a-0647-1658. Epub 2018 Aug 2.

2. Budd-Chiari syndrome has different presentations and disease severity during adolescence.
Shukla A, Bhatt P, Gupta DK, Modi T, Patel J, Gupte A, Meshram M, Bhatia S.
Hepatol Int. 2018 Jul 3. doi: 10.1007/s12072-018-9880-z. [Epub ahead of print]

3. Long-term Outcomes of Endoluminal Sharp Recanalization of Occluded Inferior Vena Cava in Budd-Chiari Syndrome.
Bi Y, Yu Z, Ding P, Ren J, Zhou P, Han X.
J Laparoendosc Adv Surg Tech A. 2018 Jul 23. doi: 10.1089/lap.2018.0385. [Epub ahead of print]

4. Transjugular Intrahepatic Portosystemic Shunt Through the Strut of a Previously Placed Stent: Technical Feasibility and Long-Term Follow-Up Results.
Ahmed M, Keshava SN, Moses V, Chiramel GK, Mammen S, Eapen CE, Zachariah UG.
Cardiovasc Intervent Radiol. 2018 Jul 16. doi: 10.1007/s00270-018-2033-x. [Epub ahead of print]

5. Pattern of Vascular Involvement in Egyptian Patients with Budd-Chiari Syndrome: Relation to Etiology and Impact on Clinical Presentation.
A Sakr M, Abdelhakam SM, Dabbous HM, Abdelmoaty AS, Ebada HE, Al-Banna WM, Ghazy MS, Aboelmaaty ME, Eldorry AK.
Ann Hepatol. 2018 July – August ,;17(4):638-644. doi: 10.5604/01.3001.0012.0933.

6. The role of transjugular intrahepatic portosystemic shunt in the management of portal vein thrombosis: a systematic review and meta-analysis.
Valentin N, Korrapati P, Constantino J, Young A, Weisberg I.
Eur J Gastroenterol Hepatol. 2018 Aug 1. doi: 10.1097/MEG.0000000000001219. [Epub ahead of print]

7. Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis.
Artaza T, Lopes M, Romero M, Gómez AZ, de la Cruz G, Sánchez JJ, González C, Gómez R.
Gastroenterol Hepatol. 2018 Jul 24. pii: S0210-5705(18)30190-0. doi: 10.1016/j.gastrohep.2018.06.005. [Epub ahead of print] English, Spanish.

8. Acute Portal Vein Thrombosis Predicts Concomitant Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients.
Khoury T, Massarwa M, Hazou W, Daher S, Hakimian D, Benson AA, Ashqar T, Mahamid M, Yaari S.
J Gastrointest Cancer. 2018 Jul 25. doi: 10.1007/s12029-018-0149-5. [Epub ahead of print]

9. Catheter-directed Thrombolysis Combined with Anticoagulation for Acute Extensive Portal Vein Thrombosis: Our Experience.
Xu Z, Tang L, Zhao Y, Gao M, Yang S.
J Dig Dis. 2018 Jul 24. doi: 10.1111/1751-2980.12649. [Epub ahead of print]

10. Long-term outcomes of transmesenteric portal vein recanalization for the treatment of chronic portal vein thrombosis after pediatric liver transplantation.
Cavalcante ACBS, Zurstrassen CE, Carnevale FC, Pugliese RPS, Fonseca EA, Moreira AM, Matushita J Jr, Cândido HLL, Benavides MAR, Miura IK, Danesi VLB, Hirschfeld APM, Borges CBV, Porta G, ChapChap P, Seda-Neto J.
Am J Transplant. 2018 Jul 18. doi: 10.1111/ajt.15022. [Epub ahead of print]

11. Liver Stiffness Measurements in Patients with Non-cirrhotic Portal Hypertension – The Devil is In the Details.
Vuppalanchi R, Mathur K, Pyko M, Samala N, Chalasani N.
Hepatology. 2018 Jul 17. doi: 10.1002/hep.30167. [Epub ahead of print]

12. β-Blockers Improve Presinusoidal Portal Hypertension.
Sørensen M, Larsen LP, Villadsen GE, Aagaard NK, Grønbæk H, Keiding S, Vilstrup H.
Dig Dis Sci. 2018 Jul 12. doi: 10.1007/s10620-018-5186-1. [Epub ahead of print]

13. Newer Oral Anticoagulants in the Treatment of Acute Portal Vein Thrombosis in Patients with and without Cirrhosis.
Priyanka P, Kupec JT, Krafft M, Shah NA, Reynolds GJ.
Int J Hepatol. 2018 Jun 5;2018:8432781. doi: 10.1155/2018/8432781. eCollection 2018. Review.

14. Hepatic and renal end-organ damage in the Fontan circulation: A report from the Australian and New Zealand Fontan Registry.
Wilson TG, d’Udekem Y, Winlaw DS, Cordina RL, Celermajer DS, Wheaton GR, Bullock A, Gentles TL, Weintraub RG, Justo RN, Grigg LE, Radford DJ, Hardikar W, Cheung M, Cain TM, Rao P, Alexander SI, Ayer J, Verrall C, Du Plessis K, Chapman J, Rice K, Barry J, Zannino D, Iyengar AJ; Australian and New Zealand Fontan Registry.
Int J Cardiol. 2018 Jul 25. pii: S0167-5273(18)30069-X. doi: 10.1016/j.ijcard.2018.07.118. [Epub ahead of print]

15. Hepatic Changes in the Fontan Circulation: Identification of Liver Dysfunction and an Attempt to Streamline Follow-up Screening.
Ackerman T, Geerts A, Van Vlierberghe H, De Backer J, François K.
Pediatr Cardiol. 2018 Jul 21. doi: 10.1007/s00246-018-1937-1. [Epub ahead of print]

16. Heart and heart-liver transplantation in adults with failing Fontan physiology.
Reardon LC, DePasquale EC, Tarabay J, Cruz D, Laks H, Biniwale RM, Busuttil RW, Kaldas FM, Saab S, Venick RS, Lin JP, Nsair A, Deng MC, Ardehali A, Caderias M, Iygengar A, Aboulhosn JA.
Clin Transplant. 2018 Jun 26:e13329. doi: 10.1111/ctr.13329. [Epub ahead of print]

[Author]

Posts